Inovio Pharmaceuticals has laid off staff and prioritized programs to focus on its lead rare disease candidate, which is ...

China’s medical regulator has granted a world-first commercial green light to a brain-computer interface, with a system ...

Welcome to this week's Chutes & Ladders, our roundup of significant leadership hirings, firings and retirings across the ...

Novo Holdings saw its assets shrink by a third last year as part of the fallout of Novo Nordisk’s nosediving share price. | ...

Immutep and the Australian biotech’s investors have been caught off guard by the unexpected failure of its LAG-3 candidate in a phase 3 study. | Immutep and the Australian biotech’s investors have ...

In a 14-month follow-up, Sana Biotechnology has found that its investigational allogeneic cell therapy continued to produce insulin in one patient with Type 1 diabetes, with no safety concerns ...

Insulet has begun recalling specific lots of its Omnipod 5 insulin pumps in the U.S. | The diabetes tech company said it is aware of 18 cases of serious complications related to the under-delivery of ...

This is a developing story. Please check back for updates. | After a tumultuous tenure marked by recent clashes with the ...

A new method for safely inserting large chunks of DNA into genomes has now measured up in mice, potentially paving the way ...

“Strategic transformations are a common and often successful approach in biotechnology,” Rami Levin, who took over as CEO of ...

BD has inked a technological partnership with automation provider Sinteco, aimed at pharmacy robotics. | The goal is to ...

In a strikingly blunt briefing, a senior FDA official accused uniQure of pushing “distorted” data to mask a “failed” therapy ...